GSK's two predecessor companies, SmithKline Beecham and Glaxo Wellcome, which merged to form GSK in 2000, had been among the first to invest in gene-hunting technology that scientists once thought would fast lead to a bushelful of new drugs.
FORBES: Magazine Article